Patent details

Basic Information

Publication number:

EP3250927

PCT Application Number:

US2016015344

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167045251

PCT Publication Number:

WO2016123329

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

GENE EXPRESSION MARKERS AND TREATMENT OF MULTIPLE SCLEROSIS

French Title of Invention:

MARQUEURS D'EXPRESSION GÉNIQUE ET TRAITEMENT DE LA SCLÉROSE EN PLAQUES

German Title of Invention:

GENEXPRESSIONSMARKER UND BEHANDLUNG VON MULTIPLER SKLEROSE

SPC Number:

Dates

Filing date:

28/01/2016

Grant date:

19/02/2020

EP Publication Date:

06/12/2017

PCT Publication Date:

04/08/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/02/2020

EP B1 Publication Date:

19/02/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/01/2021

Expiration date:

28/01/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/02/2020

 

 

Name:

F. Hoffmann-La Roche AG

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:

TOWNSEND, Michael

Address:

United States (US)

2

Name:

STATON, Tracy

Address:

United States (US)

3

Name:

SETIADI, Alvernia Francesca

Address:

United States (US)

Priority

Priority Number:

201562108914 P

Priority Date:

28/01/2015

Priority Country:

United States (US)

Classification

IPC classification:

G01N 33/564;

Publication

European Patent Bulletin

Issue number:

202008

Publication date:

19/02/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages